finalprogrambrochure - cardiometabolic health congress · 6...

Final Program Brochure

MEDICALEDUCATIONRESOURCES, INC.A Non-Profit Company

www.cardiometabol ichealth.orgThis ac2vity is jointly sponsored by HealthScience Media, Inc. (HSM), and Medical Educa2on Resources, Inc. (MER).

American College ofPreventive Medicine

Society ofAtherosclerosis

Imaging andPrevention

Association ofPhysicians Assistants

in Cardiology

American Heart AssociationCouncils on Arteriosclerosis, Thrombosis, and Vascular Biology;

Clinical Cardiology; Cardiovascular Nursing;Epidemiology and Prevention;

Nutrition, Physical Activity, and Metabolism;High Blood Pressure Research;

and Kidney in Cardiovascular Disease

Mar2n Abrahamson, MDLouis Aronne, MDSilva Arslanian, MDGeorge Bakris, MDEugene Braunwald, MDJohn Buse, MD, PhD, CDEChristopher Cannon, MDTimothy Church, MD, MPH, PhDDavid D’Alessio, MDJaime Davidson, MDMichael Davidson, MDVivian Fonseca, MDKeith Ferdinand, MDJeffrey Friedman, MD, PhDOm Ganda, MD

Thomas Giles, MDHenry Ginsberg, MDRonald Goldberg, MDAlan Gradman, MDByron Hoogwerf, MDEdward Horton, MDRichard Kahn, PhDRobert Kushner, MDJack Leahy, MDHarold Lebovitz, MDAlice Lichtenstein, DScDavid Ludwig, MD, PhDR. Preston Mason, PhDPeter McCullough, MD, MPHNancy Houston Miller, RN, BSN

Anne Peters, MDMarc Pfeffer, MD, PhDJorge Plutzky, MDRichard Pratley, MDDaniel Rader, MDMarc Saba2ne, MD, MPHSidney Smith, Jr., MDThomas Wadden, PhDMa3hew Weir, MDPeter Wilson, MDCarol Wysham, MD

CHAIRPERSONS

ASSOCIATION SUPPORTERS

Chris2e M. Ballantyne, MDBaylor College ofMedicine

Robert H. Eckel, MDUniversity of Colorado DenverAnschutzMedical Campus

Richard W. Nesto, MDLahey ClinicMedical Center

Jay S. Skyler, MDUniversity ofMiami

Miller School ofMedicine

OCTOBER 15-18, 2008•

KEYNOTE SPEAKERS

C. Ronald Kahn, MDHarvardMedical SchoolJoslin Diabetes Center

Peter Libby, MDBrigham andWomen’s Hospital

HarvardMedical School

Paul Ridker, MDBrigham andWomen’s Hospital

FACULTY

TYPE 2 DIABETES

. . .

CHRONIC KIDNEY DISEASE

. . .

INSULIN RESISTANCE

. . .

ATHEROSCLEROSIS

. . .

HYPERTENSION

. . .

DYSLIPIDEMIA

. . .

OBESITY

. . .

STROKE

2 October 15-18, 2008 · Sheraton Boston Hotel · Boston, MA2 October 15-18, 2008 · Sheraton Boston Hotel · Boston, MA

Chairpersons, Keynote Presenters & Panelists

ChairpersonsChairpersons

Keynote PresentersKeynote Presenters

New Insights into Mechanisms ofNew Insights into Mechanisms ofInsulin ResistanceInsulin Resistance

C. Ronald Kahn, MDC. Ronald Kahn, MDMaryK. IacoccaProfessor ofMedicineHarvardMedical SchoolViceChairmanof theBoardJoslinDiabetes Center

Update on MechanismsUpdate on Mechanismsof Atherosclerosisof Atherosclerosis

Peter Libby, MDPeter Libby, MDChief, CardiovascularMedicineBrighamandWomen’sHospitalMallinckrodt Professor ofMedicineHarvardMedical School

The Evolving Role of BiomarkersThe Evolving Role of Biomarkersfor CM Risk Detec2onfor CM Risk Detec2on

Paul Ridker, MDPaul Ridker, MDDirector, Center for CardiovascularDiseasePreventionBrighamandWomen’sHospital

Case-Based Discussions & PanelistsCase-Based Discussions & Panelists

Simultaneous Management of Dyslipidemia, Hypertension, and Type 2 Diabetes in the Individual Pa2ent:Simultaneous Management of Dyslipidemia, Hypertension, and Type 2 Diabetes in the Individual Pa2ent:How to Beat the Odds and Treat to GoalHow to Beat the Odds and Treat to Goal

Chris2e M. Ballantyne, MDChris2e M. Ballantyne, MDAssociate Chief andProfessor ofMedicineDirector, Center for CardiovascularDiseasePreventionCo-director, LipidMetabolism&Atherosclerosis ClinicBaylor CollegeofMedicine

Robert H. Eckel, MDRobert H. Eckel, MDProfessor ofMedicineDivisionof Endocrinology,Metabolism, andDiabetesDivisionof CardiologyCharlesA. Boettcher II Chair inAtherosclerosisProgramDirector, AdultGeneral Clinical ResearchCenterUniversity of ColoradoDenverAnschutzMedical CampusDirector, Lipid Clinic, UniversityHospital

Jay S. Skyler, MDJay S. Skyler, MDProfessor ofMedicine, Pediatrics&PsychologyDivisionof Endocrinology, Diabetes&MetabolismUniversity ofMiamiMiller School ofMedicineAssociateDirector forAcademic ProgramsDiabetes Research Institute

Richard W. Nesto, MDRichard W. Nesto, MDAssociate ProfessorHarvardMedical SchoolChair, Department of CardiovascularMedicineLaheyClinicMedical Center

Christopher Cannon, MDChristopher Cannon, MDSenior Investigator, TIMI StudyGroupBrighamandWomen’sHospitalAssociate Professor ofMedicineHarvardMedical School

Jorge Plutzky, MDJorge Plutzky, MDDirector, TheVascularDiseasePreventionProgramBrigham and Women’s HospitalAssociate Professor of MedicineHarvard Medical School

Clinical Controversies in Lipid ManagementClinical Controversies in Lipid Management

Henry Ginsberg, MDHenry Ginsberg, MDIrving Professor ofMedicineColumbiaUniversity CollegeofPhysicians and SurgeonsDirector, IrvingCenter for ClinicalandTranslational Research

Nancy Houston Miller, RN, BSNNancy Houston Miller, RN, BSNProfessorStanfordUniversitySchool ofMedicine

Daniel Rader, MDDaniel Rader, MDDirector, PreventiveCardiovascularMedicine &Lipid ClinicPennCardiac Careat PresbyterianMedical Center

Peter McCullough, MD, MPHPeter McCullough, MD, MPHChief, DivisionofNutritionandPreventiveMedicineMedical Director, PreventiveCardiologyWilliamBeaumontHospital

“The management of diabetes is evolving quickly with new therapeu.c agents and several landmarkstudies repor.ng in June of this year. Discussing these advances in the context of cardiovascular riskmanagement is cri.cal for establishing best prac.ces in pa.ent care.”- John Buse, MD, PhD, CDE

3www.cardiometabolichealth.org 3www.cardiometabolichealth.org

Distinguished Faculty

Martin Abrahamson, MDMartin Abrahamson, MDMedical Director & Senior Vice PresidentJoslin Diabetes CenterAssociate Professor ofMedicineHarvardMedical School

George Bakris, MDGeorge Bakris, MDProfessor ofMedicine and DirectorHypertensive Diseases UnitSection of Endocrinology, Diabetes andMetabolismUniversity of Chicago Pritzker School ofMedicine

David Ludwig, MD, PhDDavid Ludwig, MD, PhDDirector, OptimalWeight for Life ProgramChildren’s Hospital BostonAssociate Professor, PediatricsHarvardMedical School

Timothy Church, MD, MPH, PhDTimothy Church, MD, MPH, PhDProfessor, John S.McIllhenny Endowed Chairin HealthWisdomPennington Biomedical Research Center

Michael Davidson, MDMichael Davidson, MDMedical Director and FounderRadiant ResearchAssistant Professor ofMedicineRushMedical College

Jeffrey Friedman, MD, PhDJeffrey Friedman, MD, PhDProfessorRockefeller UniversitySenior InvestigatorHoward HughesMedical Institute

Ronald Goldberg, MDRonald Goldberg, MDProfessor ofMedicine, Biochemistry, andMolecular Biol-ogy Division of Endocrinology, Diabetes, andMetabolismUniversity ofMiamiMiller School ofMedicineAssoc. Dir. ofMedical Affairs, Diabetes Research InstituteDirector, Lipid Disorders Unit

Edward Horton, MDEdward Horton, MDSection Head, Clinical ResearchDirector, Outpatient Clinical Research CenterVice PresidentJoslin Diabetes Center

Jack Leahy, MDJack Leahy, MDProfessor ofMedicineChief, Endocrinology, Diabetes, andMetabolismUnitUniv. of Vermont College ofMedicine

Louis Aronne, MDLouis Aronne, MDDirector, ComprehensiveWeight Control ProgramNew York-Presbyterian HospitalClinical Professor ofMedicineWeill-Cornell Medical College

Eugene Braunwald, MDEugene Braunwald, MDDistinguished Hersey Professor ofMedicineHarvardMedical SchoolChairman, TIMI GroupBrigham andWomen’s Hospital

R. Preston Mason, PhDR. Preston Mason, PhDPresidentElucida Research Cardiovascular InstituteSenior Research StaffBrigham andWomen’s HospitalHarvardMedical School

David D'Alessio, MDDavid D'Alessio, MDProfessor, Dept ofMedicineDirector, Division of Endocrinology, Diabetes andMetabolismUniversity of Cincinnati

Keith Ferdinand, MDKeith Ferdinand, MDAdjunct Clinical ProfessorMorehouse School ofMedicineClinical Professor, Emory UniversityChief Science OfficerAssociation of Black Cardiologists (ABC)

Om Ganda, MDOm Ganda, MDDirector, Lipid ClinicJoslin Diabetes Center

Alan Gradman, MDAlan Gradman, MDDivision of Cardiovascular DiseasesTheWestern Pennsylvania HospitalProfessor ofMedicineTemple University

Richard Kahn, PhDRichard Kahn, PhDChief Scientific andMedical OfficerAmerican Diabetes Association

Harold Lebovitz, MDHarold Lebovitz, MDProfessor ofMedicineDivision of Endocrinology &Metabolism/DiabetesState University of New YorkHealth Sciences Center at Brooklyn

Silva Arslanian, MDSilva Arslanian, MDRichard L. Day Professor of PediatricsChildren’s Hospital of PittsburghUniversity of PittsburghMedical Center (UPMC)Director, Pediatric Clinical & Translational Research CenterWeightManagement andWellness Center

John Buse, MD, PhD, CDEJohn Buse, MD, PhD, CDEProfessor ofMedicineDirector, Diabetes Care CenterChief, Division of EndocrinologyDepartment ofMedicineUniversity ofNorthCarolina School ofMedicine at ChapelHill

Jaime Davidson, MDJaime Davidson, MDClinical Professor ofMedicineDivision of EndocrinologyUniversity of TexasSouthwesternMedical School

Vivian Fonseca, MDVivian Fonseca, MDProfessor ofMedicine and PharmacologyTullis Tulane Alumni Chair in DiabetesChief, Section of EndocrinologyTulane University Health Sciences Center

Thomas Giles, MDThomas Giles, MDProfessor ofMedicineTulane University

Byron Hoogwerf, MDByron Hoogwerf, MDStaff PhysicianDepartment of EndocrinologyMember, Cardiac Prevention ClinicCleveland Clinic

Robert Kushner, MDRobert Kushner, MDProfessor, Division of General InternalMedicineFeinberg School ofMedicineNorthwestern University

Alice Lichtenstein, DScAlice Lichtenstein, DScGershoff Professor of Nutrition Science & PolicyTufts UniversityDirector of Cardiovascular Nutrition LaboratoryJeanMayer USDAHumanNutritionResearch Center on Aging at Tufts University

Anne Peters, MDAnne Peters, MDProfessor ofMedicineUniversity of Southern California Keck School ofMedicineDirector, Clinical Diabetes Programs

Marc Pfeffer, MD, PhDMarc Pfeffer, MD, PhDDzau Professor ofMedicineHarvardMedical SchoolCardiovascular DivisionBrigham andWomen’s Hospital

Richard Pratley, MDRichard Pratley, MDProfessor ofMedicineDirector, Diabetes &MetabolismTranslationalMedicine UnitUniversity of Vermont College ofMedicine

Marc Sabatine, MD, MPHMarc Sabatine, MD, MPHAssociate Physician, Cardiology Division;Investigator, TIMI Study GroupBrigham andWomen's Hospital

FACULTY CONFIRMED AS OF 8/12/08

“Cardiometabolic risk is the new paradigm that challenges us to understand pa.ents' risk for developingcardiovascular disease and diabetes. This conference is THE place to hear all the latest informa.on onCM risk.” - Christopher Cannon, MD

Sidney Smith, Jr., MDSidney Smith, Jr., MDProfessor ofMedicineDirector, Center of Cardiovascular Science andMedicineUniversity of North Carolina at Chapel Hill

Thomas Wadden, PhDThomas Wadden, PhDProfessor of Psychology in PsychiatryUniversity of Pennsylvania

Matthew Weir, MDMatthew Weir, MDProfessor and DirectorDivision of NephrologyUniversity ofMaryland School ofMedicine

Peter Wilson, MDPeter Wilson, MDProfessor ofMedicine, Cardiology DivisionEmory University School ofMedicine

Carol Wysham, MDCarol Wysham, MDClinical Assistant Professor ofMedicineUniversity ofWashington School ofMedicineSection Head, Department of EndocrinologyRockwood Clinic

4 October 15-18, 2008 · Sheraton Boston Hotel · Boston, MA

“Diabetes, obesity, and metabolic syndrome are increasing at epidemic rates. If we don’t reverse course, thelong-term complica.ons of these diseases will be the greatest challenge in healthcare for the 21st century.”- C. Ronald Kahn, MD

Dear Colleague,

Please join us and our dis.nguish

ed faculty for the 2008 Cardiom

etabolic Health Congress,

taking place October 15-18, 200

8, at the Sheraton Hotel in Bosto

n,MA. Our third annual

congress is the largest U.S.-base

d, mul.disciplinary cardiometabolic event o

f the year – drawing

over 1,000 clinicians specializing

in cardiology, endocrinology, prim

ary care, and nephrology.

Themanagement of cardiometabolic risk (including diabetes,

obesity, hypertension,

atherosclerosis,dyslipidemia, and CKD) is e

volving quickly with new therapeu.c age

nts and

several landmark studies repor.ng this year –

many of whichwill have tremendous impact on

your prac.ce and your pa.ents.

With this inmind, our educa.onal sessions wi

ll translate the

latest clinical data from current research

and trial resultsinto themost prac.cal stra

tegies

to prevent, delay, andmanage type 2 dia

betes and cardiovascular disease

.

The congress curriculumwill be packedw

ith world-renowned speakers, in

terac.ve sessions,

thought-provoking panel discuss

ions, and the opportunity to ear

n 37.5 con.nuing educa.on

credits. Our diverse lineup of edu

ca.onal sessions reflects themost up-to-date a

nd

evidence-basedinforma.on available –

and promises to be our best program yet!

If you’ve been looking for amul.disciplinary, c

linically-relevanteduca.onal exp

eriencewhere

your knowledgecan rise to the n

ext level, a/endthe 2008 Cardio

metabolic Health Congress

and par.cipate in an expert-leve

l forumwhere novel ideas are generated

.

We look forward to your par.cipa

.on at the 2008Cardiometabolic Health C

ongress!

Best Regards,

Chris2e M. Ballantyne, MD

Baylor College of Medicine

Robert H. Eckel, MD

University of Colorado Denver

Anschutz Medical Campus

Richard W. Nesto, MD

Lahey Clinic Medical Center

Jay S. Skyler, MD

University of Miami

Miller School of Medicine

5www.cardiometabolichealth.org

Nearly 32 percent of U.S. adults (about 64 million individuals) havethree or more cardiometabolic risk factors.1 These risk factors includehypertension, insulin resistance or diabetes, abdominal obesity,dyslipidemia, and prothrombotic and proinflammatory states.2,3 Theaffected individuals have more than double the risk for cardiovasculardisease and nearly seven times the risk for developing diabetes. 4

Cardiovascular disease and diabetes have major health consequencesin the United States. An estimated 79.4 million U.S. adults suffer fromcardiovascular disease, and more than 870,000 died from it in 2004 —an average of 2,400 deaths each day, or one death every 36 seconds,according to the American Heart Association.5 In fact, cardiovasculardisease is the leading cause of death in the United States, surpassingcancer (about 50,000 deaths in 2004) and accidents (about 108,000deaths). The estimated economic cost of cardiovascular disease in2007 was nearly $432 billion.5

Diabetes was the sixth leading cause of death in 2002, claiming morethan 73,000 lives directly and contributing to about 224,000 additionaldeaths, according to the American Diabetes Association and theCenters for Disease Control and Prevention.6 Nearly 21 million U.S.adults suffer from diabetes (7 percent of the population), with 1.5million new cases diagnosed in 2005. Diabetics are two to four times more likely to die from cardiovascular disease, and diabetes is animportant cause of blindness and kidney disease. The total economic cost of diabetes in 2002 was $132 billion.6

Healthcare professionals can play a major role in stemming these health consequences and costs by learning to identify cardiometabolicrisk factors early and manage them properly. The 2008 Cardiometabolic Health Congress will translate the latest cutting-edge medicalresearch into practical, clinical approaches for reducing cardiovascular and metabolic risk. The goal is to provide the medical communitywith evidence-based interventions to improve health outcomes and quality of life for patients at increased risk.

Program Overview

Statement of NeedStatement of Need

Learning Objec2vesLearning Objec2vesAt the end of the congress participants will be able to:

• Explain the interrelationships between the various cardiometabolic riskfactors and their impact on cardiovascular health.

• Apply evidence-based strategies for prevention, screening, and treatmentof cardiometabolic risk factors into clinical practice.

• Identify which interventions, including lifestyle changes and various drugsin combination, aremost appropriate for particular patients based ontheir risk profile.

• Discuss the potential role of emerging therapies formanaging cardiometabolicrisk and further reducingmorbidity andmortality in affected patients.

ReferencesReferences1. Ford ES et al. “Increasing prevalence of the metabolic syndrome among U.S. adults.” Diabetes Care. 2004; 27:2444-2449.2. American Heart Association. “Metabolic Syndrome—Statistics.” Available at www.americanheart.org. Accessed December 14, 2007.3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497.4. Wilson PWF et al. “Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.” Circulation. 2005; 112: 3066-3072.5. Rosamond W et al. “Heart Disease and Stroke Statistics—2007 Update, A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.”

Available at http://circ.ahajournals.org. Accessed December 14, 2007.6. The American Diabetes Association and the Centers for Disease Control and Prevention. “National Diabetes Fact Sheet.”

Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf. Accessed December 14, 2007.

Table of ContentsTable of Contents

Advanced-level cliniciansresponsible for the prevention,diagnosis, and management ofcardiometabolic risk

Target AudienceTarget Audience

Chairpersons, Keynote Presenters & Panelists . . . . . . . . . . .2

Dis2nguished Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Le3er from Chairpersons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Program Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

AgendaMetabolic Syndrome, Obesity & Cardiovascular Risk . . . . . . . 6Diabetes, Hypertension & Chronic Kidney Disease . . . . . . . . . 7Atherosclerosis & Dyslipidemia . . . . . . . . . . . . . . . . . . . . . . . . . . 8Corporate-Supported Symposia . . . . . . . . . . . . . . . . . . . . . . . . . 9

Accredita2on . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

Boston A3rac2ons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

Travel & Publica2on Supporters . . . . . . . . . . . . . . . . . . . . . . 12

Registra2on Form . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Supporters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14

“I THOUGHT YOUR CONFERENCE WAS EXCELLENT. IT IS HELPING ME MOVE MY PRACTICE IN NEW DIRECTIONS.ALL FOR BETTER PATIENT CARE.” - BEN CO, MD (IN PRIVATE PRACTICE)

“THIS WAS ONE OF THE MOST HELPFUL MEETINGS I HAVE ATTENDED. CONGRATULATIONS ON A GREAT JOB.”STEVEN E. LIPSHULTZ, MD - UNIVERSITY OF MIAMI - MILLER SCHOOL OF MEDICINE

“THIS WAS AN EXCELLENT MEETING AND I HAVE ALREADY PLANNED TO REGULARLY ATTEND IN THE FUTURE.”PAMELA B. MORRIS, MD - DIRECTOR OF PREVENTIVE CARDIOLOGY, MEDICAL UNIVERSITY OF SOUTH CAROLINA

“RESEARCH DATA WAS CUTTING EDGE AND PRESENTERS WERE AMONG THE BEST MINDS IN MEDICAL SCIENCE.”SUSAN M. ALLEN, RN - CARDIOVASCULAR CONSULTANTS

“THE AMOUNT AND QUALITY OF THE INFORMATION PRESENTED WAS TREMENDOUS.”WILLIAM L. COULTER, PA-C - PHYSICIAN ASSISTANT - CARDIOLOGY


Metabolic Syndrome, Obesity & Cardiovascular Risk

Wednesday, October 15, 2008Wednesday, October 15, 2008

Thursday, October 16, 2008Thursday, October 16, 2008

6:30pm6:30pm -- 8:30pm8:30pm Dinner SymposiumDinner Symposium

6:30am6:30am -- 7:45am7:45am Breakfast SymposiaBreakfast Symposia

8:00am8:00am -- 8:10am8:10am Opening RemarksJay Skyler, MD

8:10am8:10am -- 8:30am8:30am KeynoteKeynote SessionSessionGlobal Cardiometabolic Risk 2008: Where We Are TodayRobert Eckel, MD; Richard Nesto, MD

8:30am8:30am -- 10:00am10:00am Dilemmas in the Management of the Metabolic SyndromeModerator: Richard Nesto, MDPresenters: Robert Eckel, MD; Sidney Smith, Jr., MD; Peter Wilson, MD

10:00am10:00am -- 10:30am10:30am Morning Break / Exhibit Hall

10:30am10:30am -- 11:15am11:15am Keynote SessionKeynote SessionNew Insights into Mechanisms of Insulin ResistanceC. Ronald Kahn, MD

11:15am11:15am -- 12:00pm12:00pm Gut Hormones and Their Impact on Metabolic ControlHarold Lebovitz, MD

12:15pm12:15pm -- 1:30pm1:30pm Lunch SymposiaLunch Symposia

1:45pm1:45pm -- 3:00pm3:00pm Integra2ng a Successful Obesity Management Program into Your Prac2ce:Diet, Exercise, and PharmacotherapyModerator: Robert Eckel, MD

Office Approach to Obesity: The Op2mal EnvironmentRobert Kushner, MDDiet: What Should You Recommend to Your Pa2ents to Reduce Cardiometabolic Risk?Alice Lichtenstein, DScCardiometabolic Risk Reduc2on: Op2mal Prescrip2on for ExerciseTimothy Church, MD, MPH, PhD

3:00pm3:00pm -- 3:30pm3:30pm A#ernoon Break / Exhibit Hall

3:30pm3:30pm -- 5:00pm5:00pm Integra2ng a Successful Obesity Management Program into Your Prac2ce:Diet, Exercise, and Pharmacotherapy (Con2nued)Moderator: Robert Eckel, MD

What Predicts Success?Thomas Wadden, PhDPharmacotherapy for Obesity: When Diet and Exercise Alone FailsLouis Aronne, MDObesity Panel DiscussionPanelists: Louis Aronne, MD; Timothy Church, MD, MPH, PhD; Robert Kushner, MD;

Alice Lichtenstein, DSc; Thomas Wadden, PhD

5:00pm5:00pm Closing RemarksRobert Eckel, MD

5:00pm5:00pm -- 6:30pm6:30pm Welcome Recep2on


“Global cardiovascular risk may not be sufficiently predicted by current risk factor assessmentand prevented by current treatments. This congress provides clinicians with the tools andtreatment strategies to diagnose cardiometabolic risk and treat appropriately to reduce CVD.”- Richard Nesto, MD


Friday, October 17, 2008Friday, October 17, 2008

Diabetes, Hypertension & Chronic Kidney Disease


8:00am8:00am -- 8:05am8:05am Opening RemarksChris.e Ballantyne, MD

8:05am8:05am -- 9:15am9:15am Keynote SessionKeynote SessionBiomarkers and Their Role in Clinical Prac2ceModerator: Chris.e Ballantyne, MD

The Evolving Role of Biomarkers for Cardiometabolic Risk Detec2onPaul Ridker, MD

Interac2ve Panel DiscussionRobert Eckel, MD; Paul Ridker, MD

9:15am9:15am -- 10:00am10:00am Late Breaking Clinical Trial Data SessionChris.e Ballantyne, MD; Robert Eckel, MD; Keith Ferdinand, MD; Jay Skyler, MD


10:30am10:30am -- 12:00pm12:00pm Contemporary Management of Type 2 Diabetes: Across the LifespanModerator: Jay Skyler, MD

Glycemic Control in Adults with Type 2 DiabetesMar.n Abrahamson, MD

Glycemic Control in Children with Type 2 DiabetesSilva Arslanian, MD

Clinical Controversies in the Preven2on and Management of Type 2 DiabetesPanelists: Mar.n Abrahamson, MD; Silva Arslanian, MD; Jaime Davidson, MD;

Edward Horton, MD; Richard Kahn, PhD; Richard Nesto, MD

12:15pm12:15pm -- 1:30pm1:30pm Lunch SymposiaLunch Symposia

1:45pm1:45pm -- 2:30pm2:30pm An Integra2ve Approach to Childhood Obesity and CVD Preven2onDavid Ludwig, MD, PhD

2:30pm2:30pm -- 3:15pm3:15pm Managing Hypertension in Pa2ents at Increased Cardiometabolic Risk:Does It Ma3er Which Drugs We Use?George Bakris, MD

3:15pm3:15pm -- 3:45pm3:45pm A#ernoon Break / Exhibit Hall

3:45pm3:45pm -- 4:30pm4:30pm CKD: A CHD Equivalent?Peter McCullough, MD, MPH

4:30pm4:30pm -- 5:15pm5:15pm Simultaneous Management of Dyslipidemia, Hypertension, and Type 2 Diabetes in theIndividual Pa2ent: How to Beat the Odds and Treat to Goal: Case-Based DiscussionChristopher Cannon, MD; Peter McCullough, MD, MPH; Jorge Plutzky, MD

5:15pm5:15pm Closing RemarksJay Skyler, MD


“Chronic kidney disease works to amplify cardiometabolic risk through a unique set of biochemicaland physiologic factors that accelerate atherosclerosis, worsen myocardial disease, cause valvularcalcifica.on, and precipitate arrhythmias.” - Peter McCullough, MD, MPH


Atherosclerosis & Dyslipidemia

Saturday, October 18, 2008Saturday, October 18, 2008

“If we don’t take steps to reverse course, the children of each successive generation seem destinedto be fatter and sicker than their parents.”- David Ludwig, MD, PhD


8:00am8:00am -- 8:15am8:15am Opening RemarksRichard Nesto, MD

8:15am8:15am -- 9:00am9:00am KeynoteKeynote SessionSessionUpdate on Mechanisms of AtherosclerosisPeter Libby, MD

9:00am9:00am -- 9:45am9:45am Clinical Management of the Hypertriglycemic Pa2entRobert Eckel, MD


10:15am10:15am -- 11:00am11:00am HDL: Advances in Clinical ManagementDaniel Rader, MD

11:00am11:00am -- 11:30am11:30am CVD Screening in Pa2ents at Increased Cardiometabolic Risk:Assessment of the Latest Technologies and Their U2lity in Clinical Prac2ceRichard Nesto, MD

11:30am11:30am -- 12:30pm12:30pm Panel DiscussionClinical Controversies in Lipid ManagementModerator: Chris.e Ballantyne, MDPanelists: Robert Eckel, MD; Henry Ginsberg, MD; Nancy Houston Miller, RN, BSN;

Daniel Rader, MD

12:30pm12:30pm Closing RemarksRichard Nesto, MD

Educa2onal Support, Sponsorship & Exhibit Opportuni2esEduca2onal Support, Sponsorship & Exhibit Opportuni2es

Formore information regarding educational support opportunities pleasecontact JeffMinerd at 732.758.0030 / [email protected].

Formore information regarding sponsorship and exhibit opportunities pleasecontact Elizabeth Coscia at 732.758.0276 / [email protected].

Don’t miss this unprecedentedopportunity to reach 1,000+

U.S.-based practicing clinicians!


Corporate-Supported Symposia

Only 2008 Cardiometabolic Health Congress registrants are eligible to attend corporate-supported symposia.Please visit www.cardiometabolichealth.org for corporate-supported symposia details and updates!

Wednesday, October 15, 2008Wednesday, October 15, 2008

6:30 PM - 8:30 PM - DINNER SYMPOSIUM

Targeting Triglycerides and HDL-C: Optimal Strategiesfor Reducing Residual Cardiovascular Risk

Christie Ballantyne, MD; Michael Davidson, MD; Jorge Plutzky, MD

Supported by an educational grant fromAbbott

Thursday, October 16, 2008Thursday, October 16, 2008

6:30 AM - 7:45 AM - BREAKFAST SYMPOSIUM

The Role of Direct Renin Inhibition in CardiometabolicRisk Reduction: A State-of-the-Science Symposiumand Case-Based Discussion

Alan Gradman, MD; Marc Pfeffer, MD, PhD; Matthew Weir, MD

Supported by an educational grant fromNovartis

12:15 PM - 1:30 PM - LUNCH SYMPOSIUM

Management of Obesity, Type 2 Diabetes, andCardiovascular Disease: A Role for CB1 Blockade?

Louis Aronne, MD; Christopher Cannon, MD; Richard Nesto, MD

Supported by an educational grant from sanofi-aventis


Targeting the Pathophysiology of Type 2 Diabetes:The Emerging Role of Incretin-Based Therapies

Vivian Fonseca, MD; Jack Leahy, MD; Richard Pratley, MD

Supported by an educational grant fromNovo Nordisk


Integrated Neurohormonal Therapy: An EmergingApproach for Cardiometabolic Risk Reduction

Jeffrey Friedman, MD, PhD; Richard Nesto, MD; Carol Wysham, MD

Supported by an educational grant fromAmylin

Friday, October 17, 2008Friday, October 17, 2008


Incretin Mimetics and Cardiometabolic Risk Reduction:Targeting Diabetes, Obesity, Hypertension, and Dyslipidemia

John Buse, MD, PhD, CDE; Byron Hoogwerf, MD; Anne Peters, MD

Supported by an educational grant fromAmylin/Lilly


Are All Beta Blockers Created Equal? The Role ofNew Generation Beta Blockade in the Treatmentof Patients at Increased Cardiometabolic Risk

George Bakris, MD; Thomas Giles, MD; R. Preston Mason, PhD

Supported by an educational grant from Forest Laboratories


New Options for Preventing Thrombotic Complicationsin Patients with Coronary Heart Disease:Novel P2Y12 Antagonists

Eugene Braunwald, MD; Christopher Cannon, MD; Marc Sabatine, MD

Supported by an educational grant fromDaiichi-Sankyo/Lilly


Comprehensive Cardiometabolic Risk Reduction:New Approaches to Targeting Type 2 Diabetes,Lipids, and Hypertension

George Bakris, MD; Om Ganda, MD; Ronald Goldberg, MD;Alan Gradman, MD

Supported by an educational grant fromDaiichi-Sankyo

Saturday, October 18, 2008Saturday, October 18, 2008


From Pipeline to Practice: The Role of DPP-4 Inhibitors inAchieving Glycemic Control

Richard Pratley, MD; David D’Alessio, MD; Jaime Davidson, MD

Supported by an educational grant from Takeda


Accredita2onAccredita2onPhysician Accredita2onThis ac.vity has been planned and implemented in accordancewith the Essen.al Areas and policies of the Accredita.onCouncil for Con.nuing Medical Educa.on through the jointsponsorship of Medical Educa.on Resources and HealthScienceMedia, Inc. Medical Educa.on Resources is accredited by theACCME to provide con.nuing medical educa.on for physicians.

Credit Designa2onMedical Educa.on Resources designates this educa.onalac.vity for amaximumof 37.5 AMA PRA Category 1 credit(s)TM.Physicians should only claim credit commensurate with theextent of their par.cipa.on in the ac.vity.

AAFP – American Academy of Family PhysiciansPrescribed Credit for PhysiciansThis program has been reviewed and is acceptable for up to37.5 Prescribed credit(s) by the American Academy of FamilyPhysicians.

Nurse Prac22oner Credit Designa2onMedical Educa.on Resources designates this educa.on ac.vityfor a maximum of 37.5 contact hours. Nurse Prac..onersshould only claim credit commensurate with the extent of theirpar.cipa.on in the ac.vity.

Nursing Accredita2onMedical Educa.on Resources is an approved provider ofcon.nuing nursing educa.on by the Colorado NursesAssocia.on, an accredited approver by the American NursesCreden.aling Center’s Commission on Accredita.on. This CEac.vity provides 37.5 contact hours. Provider approval expiresJuly 31, 2010. Provider approved by the California Board ofRegistered Nursing, Provider #CEP 12299, for 37.5 contact hours.

Registered Die22an Accredita2onThis program has been approved by the Commission on Diete.cRegistra.on for37.5 CPEUs.

Pharmacy Accredita2onMedical Educa.on Resources is accredited by theAccredita.on Council for Pharmacy Educa.on as aprovider of con.nuing pharmacy educa.on.Medical Educa.on Resources designates this

con.nuing educa.on ac.vity for 37.5 contact hours (3.75 CEUs)of the Accredita.on Council for Pharmacy Educa.on.Universal Program Number: 816-999-08-008-L01-P.Par.cipants will be required to sign in at the start of theprogram and/or complete a program evalua.on form.Statements of credit will be mailed within four weeks ofreceipt of appropriate documenta.on of course comple.on.

Accreditation

“Only with a thorough understanding of the cardiometabolic syndrome can we hope to identify those atrisk and to prevent the associated vascular complications.”- Carol Wysham, MD

2009 Cardiometabolic Health CongressOctober 7-10, 2009 - Boston, MA

SAVEtheDATE

Complimentary CME from the Cardiometabolic Health CongressComplimentary CME from the Cardiometabolic Health CongressIf you missed the 2007 Cardiometabolic Health Congress, now is your chance to learn from our distinguished faculty as they translate cutting-edgemedical research into practical, clinical strategies for managing obesity, hypertension, diabetes, dyslipidemia, and more. Presentations from the2007 congress are now available online in a multimedia format and certified for ACCME, ANCC, and CDR-ADA continuing medical education credit.

EDUCATIONAL PROGRAMS

Visit our educational website at www.cardiometabolichealth.org/education.asp

Cardiometabolic Risk Reduc2on:Emerging Therapeu.c Strategies

for Managing Obesity

The Role of An2-Hypertensive Therapiesin Cardiometabolic Risk Reduc2on

Focusing on the Bigger Lipid Picture:Targe.ng LDL, HDL, and Triglycerides forOp.mal Cardiometabolic Risk Reduc.on

Cardiometabolic Risk Iden2fica2onand Management: New Insights to

Improve Pa.ent Care


Boston Attractions

Tours & SightseeingTours & Sightseeing

Arnold Arboretum – Walking Tours125 Arborway, Jamaica Plain, MA 02130(617) 524-1718 x100Website: www.arboretum.harvard.edu

Boston Duck Tours – Land and Water TourThree Copley Place, Suite 310, Boston, MA 02116(617) 450-0068 or (800) 226-7442Website: www.BostonDuckTours.comE-mail: [email protected]

CityView Trolley ToursPO Box 267, Boston, MA 02132(617) 363-7899Website: www.cityviewtrolleys.comE-mail: [email protected]

EntertainmentEntertainment

Blue Man Group at the Charles Playhouse74 Warrenton Street, Boston, MA 02116(617) 542-6700Website: www.blueman.comE-mail: [email protected]

Boston Ballet19 Clarendon Street, Boston, MA 02116(617) 456-6343Website: www.bostonballet.org

Boston Lyric Opera45 Franklin Street, Boston, MA 02110(617) 542-6772Box Office: (617) 542-OPRA (6772)Website: www.blo.orgE-mail: [email protected]

Boston Philharmonic295 Huntington Avenue, Boston, MA 02115(617) 236-0999Website: www.bostonphil.orgE-mail: [email protected]

ImprovBoston1253 Cambridge Street, Cambridge, MA 02139(617) 576-1253 or (800) 576-1253Website: www.improvboston.comE-mail: [email protected]

“Treatment of obesity represents the final frontier in the management of many patients with highcardiovascular risk. To provide the best care possible for their patients, physicians should be familiarwith the latest methods of managing obesity and its associated cardiometabolic risk.”- Louis Aronne, MD


Travel & Publication Supporters

Hotel & Travel Informa2onHotel & Travel Informa2on

Sheraton Boston Hotel39 Dalton Street, Boston, MA 02199Ph: 617.236.2000Fax: 617.236.6095

The Sheraton Boston Hotel is located in the heart of one ofAmerica’s most historic cities – four miles from Logan Airportand blocks from the financial district, Charles River, trendyNewbury Street, and Fenway Park.

To book your hotel room, please contact the hotel directly.Mention that you are attending the 2008 CardiometabolicHealth Congress to receive our special negotiated room rate.

Book Your Hotel Accommodations Onlinehttp://www.starwoodmeeting.com/Book/CARDIOMETABOLIC2008

The 2008 Cardiometabolic Health Congress discounted room rateis available until September 29, 2008, and is subject to availability.

“With the relentless epidemic of obesity, pediatricians are faced with trea.ng children afflicted with adultdiseases, among which type 2 diabetes and cardiovascular disease are taking the lead. Our data show thatas early as the second decade of life there is evidence of premature aging of the cardiovascular system,with arterial s.ffness in adolescents with type 2 diabetes similar to 40- to 50-year-old individuals. The bigquandary is if these children will experience their first heart a/ack before their parents!”- Silva Arslanian, MD

Journal of theCardioMetabolic Syndrome

Publica2on SupportersPublica2on Supporters

Dr. Joe’sE-News


Physicians*Physicians*

Allied Health Professionals*Allied Health Professionals*

Residents/Fellows**Residents/Fellows**

IndustryIndustry

Guest Pass***Guest Pass***

Total Amount Due

Method of Payment Check Credit Card Visa MasterCard American Express Discover

Account Number Expiration Date /

Cardholder Name Cardholder Signature

Cancellation PolicyCancellations must be made in writing via fax to 866.218.9168 or e-mail to [email protected]. Refunds, less a $100 service fee, will be given if written cancellation isreceived no later than September 12, 2008. No refunds will be given after September 12, 2008. You may send a substitute, even at the last minute. To send a substitute, pleasecall 877.571.4700 or e-mail your request to [email protected].

Prefix First Name Last Name Degree(s)

Title

Affiliation

Address 1

Address 2

City State Zip Code

Tel Fax E-mail

Guest Name (if you are purchasing a guest pass):

Please indicate your specialty (check one):Cardiology Endocrinology Internal Medicine Nephrology Primary Care Industry Other

Current members of our association supporters receive a $100 discount off the registration price.*Indicate which association you are a member of below:

Month / Year

* Must be engaged in clinical practice to receive discounted rate.** ID card from school, residency, or fellowship program is required for verification. No other discounts apply.*** Guest passes are available to paid registrants only.

Registration Form

Online:Online:www.cardiometabolichealth.org

By Phone:By Phone:Jessica at 877.571.4700

By Fax:By Fax:866.218.9168

Mail Registration FormMail Registration Formwith Payment to:with Payment to:2008 Cardiometabolic Health Congressc/o HealthScienceMedia, Inc.788 Shrewsbury AvenueSuite 102Tinton Falls, NJ 07724

4 Easy Ways to Register...4 Easy Ways to Register...

Registra2on FeesRegistra2on Fees Final DiscountFinal DiscountRegister by 10/14/08Register by 10/14/08

$695

$595

$250

$1095

$100

On-SiteOn-SiteRegistrationRegistration

$795

$695

$300

$1195

$100

American Diabetes AssociationAssociation of Black CardiologistsAmerican Heart AssociationNational Kidney FoundationAmerican Society of Hypertension

The Endocrine SocietyPreventive Cardiology Nursing AssociationAmerican Society for Metabolic & Bariatric SurgeryAmerican College of Preventive MedicinePartnership for Prevention

Vascular Disease FoundationSociety for Geriatric CardiologyAmerican Society of Endocrine PAsNational Hispanic Medical AssociationSociety of Atherosclerosis Imaging & Prevention

Association of Physician Assistants in CardiologyAmerican Association of Cardiovascular& Pulmonary Rehabilitation

“In almost every area of medical practice, CVD and metabolic disorders such as obesity and diabetes arerelevant. This symposium has and will continue to provide updated information on the interaction ofCVD with metabolic disorders that will impact your practice of medicine–and again by an awesome anddistinguished faculty.” – Robert Eckel, MD

* Only one discount may be applied per registrant.


Supporters

The 2008 Cardiometabolic Health Congress gratefully acknowledges theeduca-on grant support provided by the following organiza-ons.

Pla2num SupportersPla2num Supporters

Gold SupportersGold Supporters

Silver SupportersSilver Supporters

Educa2onal SupportersEduca2onal Supporters

Associa2on SupportersAssocia2on Supporters

SUPPORTERS CONFIRMED AS OF 8/12/08

Formore information regarding educational support opportunities please contact JeffMinerd at 732.758.0030 / [email protected].

American College ofPreventive Medicine

Society ofAtherosclerosis

Imaging andPrevention

Association ofPhysicians Assistants

in Cardiology

American Heart AssociationCouncils on Arteriosclerosis, Thrombosis, and Vascular Biology;

Clinical Cardiology; Cardiovascular Nursing;Epidemiology and Prevention;

Nutrition, Physical Activity, and Metabolism;High Blood Pressure Research;

and Kidney in Cardiovascular Disease

Current Members of Our Associa-on Supporters Receive a $100 Discount!

2008 Cardiometabolic Health Congressc/o HealthScience Media, Inc.788 Shrewsbury Avenue, Suite 102Tinton Falls, NJ 07724

PRSRTSTANDARDPostage

PAIDManchester, NHPermit No. 1926

www.cardiometabol ichealth.org

“The metabolic consequences ofobesity are epidemic, with resultantcardiovascular disease killing morepeople than cancer in the U.S.”- George Bakris, MD

Final Program Brochure

OCTOBER 15-18, 2008•

“Cardiometabolic risk factors cross the boundaries ofnutri.on, epidemiology, basic science, and clinicalinterven.on. This congress brings together experts fromeach of these areas, allowing important cross-fer.liza.onof approaches and ideas.” - Byron J. Hoogwerf, MD

Discover Insights from the Expertsin Cardiometabolic Risk Management!» Over 50 world-renowned faculty translating the latest data into

practical strategies to manage multiple cardiometabolic risk factors

» Interactive sessions focusing on type 2 diabetes, obesity, insulin resistance,hypertension, dyslipidemia, chronic kidney disease, and more!

» Opportunity to network with your peers – over 1,000 U.S.-basedpracticing clinicians

» Dynamic exhibit hall featuring companies showcasing their latestproducts and services

» Complimentary breakfast, lunch, and dinner symposia

finalprogrambrochure - cardiometabolic health congress · 6...

Documents